Investment Bank Upgrades Invitrogen Stock; Shares Climb 3.6 Percent

Jun 09, 2006

NEW YORK, June 9 (GenomeWeb News) - Invitrogen's shares were up 3.6 percent, or $2.29, at $65.37 in mid-afternoon trading after Bears Sterns upgraded the company's stock to "Outperform" from "Peer Perform" today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Alan Rabson Dies

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

ECRI Institute to Offer Medical Guidelines

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

This Week in Genome Research

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

Places to Talk About It

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.

Main menu